Medical Condition News

RSS

Congressman Mike Thompson lauded for endorsing the Lung Cancer Mortality Reduction Act

Today, Lung Cancer Alliance (LCA) praised Congressman Mike Thompson (D-CA) for his endorsement of the Lung Cancer Mortality Reduction Act of 2009. Thompson joins Representatives Michael Honda (D-CA), Barbara Lee (D-CA) and Lucille Roybal-Allard (D-CA) in strengthening California's Congressional support for this critically needed legislation.

31 Oct 2009

Amgen publishes Phase 3 study results of Aranesp

Amgen today announced the publication of results from TREAT (the Trial to Reduce Cardiovascular Events with Aranesp® Therapy), a large, randomized, double-blind, placebo-controlled, Phase 3 pivotal study of patients with chronic kidney disease (CKD) not on dialysis, moderate anemia and type-2 diabetes.

31 Oct 2009

Molecular imaging pinpoints inflammation in the brains of schizophrenics and migraine sufferers

Inflammatory response of brain cells-as indicated by a molecular imaging technique-could tell researchers more about why certain neurologic disorders, such as migraine headaches and psychosis in schizophrenic patients, occur and provide insight into how to best treat them, according to two studies published in the November issue of the Journal of Nuclear Medicine.

31 Oct 2009

Dialysis patients at increased risk of infections during travel: Study

If you're sick, traveling to a foreign land may boost your spirits, but jeopardize your health, according to a paper being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA. The findings indicate that dialysis patients who travel on vacation risk infections, anemia, and other complications that can compromise their dialysis treatments.

31 Oct 2009

New report on the global addiction pharmacotherapeutic market

The world market for medicines that treat addiction disorders is currently valued at US$3.2bn is set to increase by 19% by 2016 to $3.8bn, forecasts a new market report from URCH Publishing.

31 Oct 2009

Shire announces Phase IIIb study results of Daytrana

Shire plc, the global specialty biopharmaceutical company, today announced findings at a major medical meeting from a Phase IIIb study of the tolerability and effectiveness of Daytrana® (methylphenidate transdermal system) in adolescents aged 13 to 17 years diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD).

31 Oct 2009

Race of kidney donors may affect the survival rates of transplant recipients

The race of kidney donors may affect the survival rates of transplant recipients according to a study by Henry Ford Hospital.

31 Oct 2009

Conference to address the need for gender specific diagnostic strategies for women

The 'Red Alert for Women's Hearts' conference, taking place on 5 November 2009, at the European Heart House, Sophia Antipolis, France, will address the subject of Women and CVD. The conference is jointly organised by the European Society of Cardiology (ESC) and European Heart Network (EHN), as part of Work Package 6 of the EuroHeart project .

31 Oct 2009

John Simpson named the 2009 Distinguished Alumnus for his invention

Back in the 1970s, while watching an angioplasty to widen clogged coronary arteries, John Simpson, Ph.D., M.D., thought there had to be an easier way to perform the procedure.

31 Oct 2009

Schering-Plough receives FDA complete response letter regarding PEGINTRON

Schering-Plough Corp. announced the U.S. Food and Drug Administration (FDA) has issued a complete response letter to the company's supplemental Biologics License Application regarding PEGINTRON® (pegylated interferon alfa-2b) for the adjuvant treatment of patients with stage III malignant melanoma after complete lymphadenectomy.

31 Oct 2009

Stress-evoked changes can precipitate low mood and re-ignite drug-seeking behaviors

Stress-evoked changes in circuits that regulate serotonin in certain parts of the brain can precipitate a low mood and a relapse in cocaine-seeking, based on mouse studies published online this week in the Proceedings of the National Academy of Sciences.

31 Oct 2009

Meeting to understand gastrointestinal problems in children with ASDs to be held

Autism Speaks, the American Academy of Pediatrics (AAP) and the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) will host one of the largest gatherings of researchers, clinicians and pediatric specialists to better understand the gastrointestinal (GI) problems in children with autism spectrum disorders (ASDs).

31 Oct 2009

Johns Hopkins researchers find life in blood-starved retinas; shed light on vision loss

Like all tissues in the body, the eye needs a healthy blood supply to function properly. Poorly developed blood vessels can lead to visual impairment or even blindness. While many of the molecules involved in guiding the development of the intricate blood vessel architecture are known, only now are we learning how these molecules work and how they might affect sight.

31 Oct 2009

GE Healthcare to showcase its sophisticated imaging systems for oncology at the ASTRO meeting

According to the American Cancer Society, more than one million people are diagnosed with cancer each year. In the United States, about 1 out of every 2 men and 1 out of every 3 women will have some type of cancer at some point during their lifetime. The sooner a cancer is detected and treatment begins, the better the patient’s chances for survival.

31 Oct 2009

Quintiles and Eisai partner to develop potential oncology products

Quintiles today announced a strategic alliance with leading global pharmaceutical company Eisai Co., Ltd. (Tokyo, Japan) to develop six potential oncology products in Eisai’s R&D pipeline. Under the terms of the agreement, Quintiles’ oncology experts will conduct Phase II proof-of-concept studies for 11 solid tumor indications. A key goal of the alliance is to determine the efficacy of the products in the shortest possible time in order to bring therapies to market faster for the benefit of cancer patients worldwide.

31 Oct 2009

CeloNova BioSciences submits a request for approval of its new Embozene Microsphere

CeloNova BioSciences today announced that the company is submitting to its European Notified Body a request for approval of its new, lime green, 2800 micron size Embozene(TM) Microsphere.

31 Oct 2009

Novo Nordisk re-launches its changing possibilities in hemophilia campaign

Novo Nordisk Inc. announced the re-launch of its changing possibilities in hemophilia(TM) campaign through a rebranded Web site and a new community on Facebook®. People living with hemophilia face many daily challenges, and Novo Nordisk is committed to helping this community realize that there is also a lifetime of possibilities.

From Novo Nordisk 31 Oct 2009

New diagnostic test for detecting colorectal cancer

GastroFISH™ is the first tissue-based fluorescence in situ hybridization (FISH) test for the detection of chromosomal anomalies associated with colon cancer.

31 Oct 2009

Immunotherapy, a new therapeutic area to destroy tumor cells

Targeted immunotherapy has been an attractive new therapeutic area for a number of cancers because it has the potential to destroy tumor cells without damaging surrounding normal tissue. New study results demonstrate high success rates using specialized white blood cells to prevent or treat lymphoma associated with the Epstein-Barr virus (EBV-lymphoma) in patients who have received a hematopoietic stem cell transplant (HSCT).

31 Oct 2009

Study: Gene therapy can reduce symptoms of Huntington's disease

Researchers at the California Institute of Technology (Caltech) have shown that a highly specific intrabody (an antibody fragment that works against a target inside a cell) is capable of stalling the development of Huntington's disease in a variety of mouse models.

31 Oct 2009

Medical Condition News

Congressman Mike Thompson lauded for endorsing the Lung Cancer Mortality Reduction Act

Amgen publishes Phase 3 study results of Aranesp

Molecular imaging pinpoints inflammation in the brains of schizophrenics and migraine sufferers

Dialysis patients at increased risk of infections during travel: Study

New report on the global addiction pharmacotherapeutic market

Shire announces Phase IIIb study results of Daytrana

Race of kidney donors may affect the survival rates of transplant recipients

Conference to address the need for gender specific diagnostic strategies for women

John Simpson named the 2009 Distinguished Alumnus for his invention

Schering-Plough receives FDA complete response letter regarding PEGINTRON

Stress-evoked changes can precipitate low mood and re-ignite drug-seeking behaviors

Meeting to understand gastrointestinal problems in children with ASDs to be held

Johns Hopkins researchers find life in blood-starved retinas; shed light on vision loss

GE Healthcare to showcase its sophisticated imaging systems for oncology at the ASTRO meeting

Quintiles and Eisai partner to develop potential oncology products

CeloNova BioSciences submits a request for approval of its new Embozene Microsphere

Novo Nordisk re-launches its changing possibilities in hemophilia campaign

New diagnostic test for detecting colorectal cancer

Immunotherapy, a new therapeutic area to destroy tumor cells

Study: Gene therapy can reduce symptoms of Huntington's disease

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News